The orphan Rev-erb nuclear receptors:
a link between metabolism, circadian rhythm and inflammation? by Ramakrishnan, Sathiya N. & Muscat, George E.O.
The orphan Rev-erb nuclear receptors: a link
between metabolism, circadian rhythm and
inflammation?
Sathiya N. Ramakrishnan and George E.O.  Muscat
Corresponding Author: g.muscat@imb.uq.edu.au
Institute for Molecular Bioscience, Division of Molecular Genetics and Development, The University of Queensland, St. Lucia, Australia
Nuclear hormone receptors (NRs) function as ligand dependent DNA binding proteins that translate
physiological/nutritional signals into gene regulation. Dysfunctional NR signaling leads to many disorders in
reproduction, inflammation, and metabolism.The opportunity to identify novel regulatory pathways in the
context of human health and disease drives the challenge to unravel the biological function of the “orphan
nuclear hormone receptors”. For example, the Rev-erb (NR1D) subgroup (Rev-erbα/NR1D1 and Rev-erbβ/NR1D2)
of orphan NRs are transcriptional silencers and negative regulators of ROR  mediated trans-activation.The
NR1D subgroup is highly enriched in peripheral tissues with onerous energy demands including skeletal
muscle, brown and white adipose, brain, liver and kidney.This alludes to the involvement of this subgroup
in metabolism. In this context, Rev-erbα-/- mice have a dyslipidemic phenotype. Recent studies in vascular
smooth and skeletal muscle cells also suggest that the NR1D subgroup modulates inflammation by regulating
IκBα/NFκB dependent gene expression. Rev-erbα has been identified as a critical regulator (and target) of
circadian rhythm, a factor in blood pressure control and inflammation. Finally, two recent reports have
demonstrated: (i) lithium mediated regulation of Rev-erbα stability and (ii) E75 (the Drosophila orthologue of
human Rev-erbα) is tightly bound by heme, and functions as a “gas sensor” through interaction with CO/NO
and interferes with the repression of DHR3 (the Drosophila orthologue of human RORα). In conclusion, the
role of these receptors at the cross-roads of metabolism, inflammation, and circadian cycling underscores
the importance of understanding the organ-specific function of the NR1D subgroup in homeostasis.
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The NR1D subgroup of orphan NRs,
Rev-erbα (NR1D1) and Rev-erbβ (NR1D2)
All members of the NR superfamily display a highly
conserved structural organisation with an amino terminal
AB region (that encodes activation function 1, AF-1);
followed by the C-region which encodes the DNA binding
domain (DBD); a linker region D and the C-terminal E
region.The DE region encodes the ligand binding domain
(LBD), and a transcriptional domain (in helix 12), denoted
as activation function 2 (AF-2) [Gronemeyer et al., 2004].
The Rev-erb/NR1D subgroup contains two members,
Rev-erbα (NR1D1;[Lazar et al., 1989]) and Rev-erbβ
(NR1D2; [Dumas et al., 1994; Retnakaran et al., 1994]).
The Rev-erbs, and retinoid related orphan receptors
(RORs; [Giguere et al., 1994; Laitinen and Staels, 2003]
bind as monomers to the consensus NR half-site motif,
flanked by an 6bp AT-rich sequence (A/T)6 PuGGTCA,
or as a homodimer to a direct repeat of the core motif
separated by 2 bp. Although these receptors are closely
related, and bind to the same motif, they function in an
opposing manner.The NR1D subgroup function as
dominant transcriptional silencers, and they repress
trans-activation mediated by RORα [Forman et al., 1994].
Interestingly, RORα activates Rev-erbα transcription
[Delerive et al., 2002; Raspe et al., 2002b], and Rev-erbα
represses its own transcription [Adelmant et al., 1996].
Homology modeling of the putative LBDs of the NR1D
subgroup suggested that the pocket is occupied by bulky
side chains, and the small residual cavity could not
“accommodate” a classical ligand. Concordantly, NR1D1
and 2 are the only members of the superfamily that do
not encode helix 12 and an AF-2 domain [Renaud et al.,
2000]. However, the existence of a novel small molecular
regulator cannot be precluded. Molecular modeling also
revealed a very hydrophobic surface due to the absence
of H12, exposing residues from H3, loop 3-4, H4, and
H11 that mediate corepressor recruitment.
Rev-erbs and lipid metabolism
Rev-erbα has been shown to be involved in repressing
rat apoA1 gene expression [Vu-Dac et al., 1998]. in vivo
studies have shown that apoA1 reduces free cholesterol
accumulation in atherosclerotic lesions of ApoE-deficient
mice. Moreover, human Rev-erbα and β specifically
repress apoCIII gene expression in rats [Coste and
Rodriguez, 2002] and humans [Raspe et al., 2002a].
ApoCIII is a component of HDL and VLDL that regulates
triglyceride levels and lipoprotein lipase activity. In this
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have elevated VLDL triglyceride and apoCIII levels [Raspe
et al., 2002a]. It is interesting to note that plasma
triglyceride and apoC-III protein concentrations in
staggerer (sg/sg) mice, homozygous for a deletion in the
RORα gene, were significantly lower than in wild type
littermates [Laitinen and Staels, 2003].This is in
agreement with the repression and activation of apoCIII
gene expression by Rev-erbα and RORα, respectively.
Moreover, it highlights the regulatory crosstalk between
Rev-erbα and RORα in the context of the blood lipid
profile.
Hypolipidemic fibrate drugs increase Rev-erbα expression
in human liver cells [Gervois et al., 1999]. Interestingly,
the fibrate mediated activation occurs at the transcriptional
level in a PPARα dependent manner.The mechanism
involves a previously characterized Rev-erbα response
element; a unique DR2 element whose 5’ region is flanked
by AT-rich sequence. Rev-erbα and PPARα compete for
binding to this response element in the Rev-erbα
promoter. Moreover, Rev-erbα has been shown to
modulate hydratase-dehydrogenase expression, a key
gene involved in peroxisomal β-oxidation pathway through
repression of PPARα-dependent transactivation [Kassam
et al., 1999]. Similarly, the mechanisms involved direct
binding to a PPRE, however, the Rev-erbα and PPARα
binding characteristics to the response element were
distinct. Furthermore, fibrates regulate apoA1 gene
expression in a species specific manner. For example,
fibrates increase and decrease apoA1 expression in
humans and rats respectively. Firstly, the repression of
apoA1 expression in fibrates is due to a 3 nucleotide
difference in the rat promoter that produces a
non-functional PPARα response element. Secondly, the
rat but not the human promoter harbors a Rev-erbα
response element that mediates Rev-erbα dependent
repression in the presence of fibrates.These studies
underscore the crosstalk between Rev-erbα and PPARα
in the control of lipid homeostasis.
Rev-erbα and β are regulated in a biphasic manner during
DMI (Dexamethasone/IBMX/Insulin) and rosiglitazone
induced adipocyte differentiation [Chawla and Lazar,
1993; Fu et al., 2005; Laitinen et al., 2005]. Rosiglitazone
induced adipogenesis involves PPAR-γ mediated
induction of Rev-erbα mRNA expression. In agreement,
exogenous expression of Rev-erbα in 3T3-L1 cells
promoted adipogenic differentiation [Fontaine et al., 2003].
In contrast, Rev-erbα and β antagonistically regulate
mammalian muscle differentiation and their expression
levels decrease during myogenesis [Burke et al., 1996;
Downes et al., 1995].
In vivo studies in mice suggest that Rev-erbα is
preferentially expressed in fast-twitch type IIB and
intermediate typeIIA fibers. Moreover, in slow twitch (type
I) soleus muscle of Rev-erbα homozygous and
heterozygous null mutant mice, there is a significant
increase in the expression of the β/slow myosin heavy
chain (MyHC) isoform [Pircher et al., 2005].Type IIB fast
fibers utilize glycolysis, in contrast, type IIA combine fast
twitch glycolytic capacity with aerobic metabolism.Type
I fibers are dependent on the aerobic metabolism of fatty
acids.The expression of Rev-erbα in energy demanding
tissues, the fiber specific expression characteristics, and
the effect of the null mutation on the muscle phenotype
suggest a role in metabolism.
In this context, it has been shown that ectopic Rev-erbβΔE
(that lacks the LBD) expression in skeletal muscle cells
attenuated the expression of many genes involved in fatty
acid/lipid absorption (including FAT/CD36, FABP-3 and
-4), and an expected increase in RORα expression
[Ramakrishnan et al., 2005]. Interestingly, these authors
reported a dramatic decrease in the expression of the
mRNA encoding myostatin, a TGF-β family member that
plays a crucial role in regulating muscle and adipose mass
[Gonzalez-Cadavid and Bhasin, 2004]. Myostatin -/- mice
have increased skeletal muscle mass (from muscle
hypertrophy and hyperplasia) accompanied by decreased
adiposity. McPherron and Lee reported that the
introduction of the myostatin mutation in mouse models
of obesity and diabetes, suppressed fat accumulation
and hyperglycemia [McPherron and Lee, 2002].The
Rev-erbα and Rev-erbβ target genes and tissues are
schematically depicted in Figure 1.
Figure 1. Target genes of the NR1D subgroup. “Rev-erbs” regulate
gene expression events in various species and tissues. Genes listed
include primary and secondary targets that have been documented in the
literature.
Rev-erbs and circadian rhythm
Rev-erbα is involved in circadian timing in brain and liver
tissue, and regulates BMAL1, and to a lesser extent
CLOCK expression (see Figure 2) [Balsalobre et al., 1998;
Torra et al., 2000]. Rev-Erbα itself is driven directly by
the molecular oscillator, it is activated by the
BMAL1-CLOCK heterodimer, and repressed by
PERIOD1/2 and CRYPTOCHROME1/2 proteins [Preitner
et al., 2002;Triqueneaux et al., 2004]. It is interesting to
note that Rev-erbα and RORα opposingly regulate Bmal1
expression and are an integral component of a complex
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et al., 1998; Emery and Reppert, 2004; Sato et al., 2004;
Torra et al., 2000].The amplitude of Bmal1, Clock, and
Cry1 mRNA oscillations are significantly attenuated in
Rev-erbα -/- mice. Rev-erbα has been shown to influence
period length and phase shifting. Schibler and colleagues
demonstrated that Rev-erbα -/- mice kept under constant
darkness and constant light conditions had a shorter
period length compared to wild-type animals [Preitner et
al., 2002]. Curiously, the maintenance of circadian
pacemaker by Rev-erbα is also conserved in other
organisms such as zebrafish [Delaunay et al., 2000].
Laudet and colleagues have hypothesized that Rev-erbα
can function as integrator of circadian and physiological
events [Triqueneaux et al., 2004].The literature provides
copious examples of circadian regulation of blood
pressure, and hypertensive fluctuations associated with
cardiovascular disease [Giles, 2005; Ikeda et al., 2004].
Furthermore, aberrant sleep cycles in humans lead to
increased secretion of proinflammatory cytokines (for
example TNFα and IL-6) [Vgontzas et al., 2004] and
reduced cortisol secretion [Takahashi et al., 2001]. In this
context, mice treated with prednisolone repressed
Rev-erbα and Bmal1 expression [Koyanagi et al., 2006].
Very recently, Yin et al. demonstrated that glycogen
synthase kinase 3 (GSK3)-mediated phosphorylation of
Rev-erbα and stabilizes the expression of the nuclear
receptor [Yin et al., 2006]. Excitingly, they went on to
demonstrate that lithium treatment (commonly used to
treat bipolar disorder) leads to proteosomal degradation
of Rev-erbα and induction of Bmal 1.This process is
mediated by lithium induced inhibition of GSK3. Finally,
a report from Cermakian and colleagues also highlights
that Rev-erbβ can regulate circadian transcription of the
Bmal1 gene [Guillaumond et al., 2005].
Figure 2. Cross-talk between Rev-erbα and RORα signaling in
circadian gene regulation. Rev-erbα and RORα mutually regulate
circadian Clock genes. Dysregulation in these pathways leads to chronic
disease state such as metabolic syndrome.
Rev-erbs and inflammation
Lipopolysaccharide induced activation of bone marrow
derived macrophages induces biphasic regulation of
Rev-erbβ [Barish et al., 2005]. Recent studies have shown
that inflammatory cytokines play crucial roles in
endothelial and smooth muscle cell responses in diseases
associated with the vasculature.Vascular smooth muscle
cells over-expressing Rev-erbα induced NF-κB mediated
trans-activation (and p65 translocation). In addition,
increased expression of the pro-inflammatory cytokines
IL-6 and COX-2 was observed [Migita et al., 2004].
Concordantly, ectopic expression of RORαin human
smooth muscle cells inhibits TNFα mediated induction of
IL-6, IL-8, and COX-2 expression through induction of
IκBα [Delerive et al., 2001].The attenuation of Rev-erbβ
expression/function in skeletal muscle cells has been
reported to induce IL-6 mRNA expression. Paradoxically,
this was associated with increased expression of RORα
and IκBα [Ramakrishnan et al., 2005]. IL-6 is an exercise
induced myokine that induces lipolysis in adipose tissue,
and suppresses TNFα production.The increased
expression of IL-6 is consistent with decreased myostatin
expression. For example, it has been reported that IL-6
deficiency leads to late-onset obesity [Wallenius et al.,
2002], whereas myostatin deficiency leads to the reduced
accumulation of body fat [McPherron and Lee, 2002].
Therefore, the inverse correlation between IL-6 and
myostatin expression after attenuation of Rev-erbβ
expression is in concordance with the reported phenotypic
effects of these proteins.The studies above highlight the
emerging role of Rev-erbs in the inflammation cascade.
Figure 3. A speculative model for ligand-dependent Rev-erbα
modulation in mammals. Like Drosophila, endogenous molecules such
as heme and diatomic gases could possibly bind to Rev-erbα and
activate/modulate its ability to trans-repress RORα and other gene
expression events.
Concluding remarks and future
directions
Molecular modeling suggests the cavities in the LBDs of
the NR1D subgroup are occupied by bulky side chains.
This indicates that pharmacological manipulation of this
orphan NR subgroup by agonists and antagonists in the
near future may present technical challenges. However,
a recent report from Reinking et al [Reinking et al., 2005]
has shown that the ligand binding pocket of E75, a
Drosophila orthologue of human Rev-erbα is tightly bound
by heme. In recent years, various heme containing
molecules have been identified to regulate lipid
homeostasis. For example, heme containing neuronal
nitric oxide synthase regulates genes involved in the
lipogenesis pathway [Schild et al., 2006]. Curiously,
Reinking and colleagues also identified E75 as a potential
gas sensor and that CO or NO bind to E75 to interfere
with E75 mediated repression of DHR3, a Drosophila
orthologue of human RORα, see Figure 3). Moreover,
heme, NO and CO are important regulatory molecules in
mammalian circadian clocks (reviewed in [Pardee et al.,
2004]). Recently, cholesterol/cholesterol sulphate and
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RORβ agonists, respectively [Kallen et al., 2004; Kallen
et al., 2002; Stehlin-Gaon et al., 2003]. In summary, these
studies suggest that identification of novel synthetic small
molecule regulators for the NR1D subgroup by
contemporary chemistry in the near future is possible.
Further insights into the function of the NR1D subgroup
in the short term will require targeted genetic analysis of
both Rev-erbα and β in specific tissues and organs. Cell
specific attenuation of the NR1D subgroup (by Cre-Lox
and/or transgenic techniques) in the major mass tissues
(including skeletal muscle, liver and adipose tissue) will
provide novel insights into the physiological role of these
orphan NRs in metabolism.
The NR1D subgroups are transcriptional silencers, and
identification of target genes is certainly an area requiring
additional study. Current studies indicate Rev-erb
signaling impacts on RORα and PPARα-mediated control
of inflammation and metabolism. Furthermore, it is
increasingly apparent that Rev-erbα is an integral
component of complex transcriptional feedback loops
that are involved in circadian control. Complete elucidation
of the pathophysiologically relevant targets of the
Rev-erbs and the crosstalk with other NR signaling
pathways in a cell/organ specific context will provide
unique insights into the links between metabolism,
inflammation and the circadian cycle in homeostasis.
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